FDA approves new nonopioid pain medication, hailed a 'triumph'
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain. Vertex Pharmaceuticals’ suzetrigine, which will be marketed under the name Journavx, targets specific sodium channels that help pass signals on from the site of pain.
Hosted on MSN12m
FDA approves opiate-alternative acute pain management drug, local experts share their thoughtsOn Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
5don MSN
If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...
The following is a summary of “Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback